Published in Tissue Eng Part B Rev on August 08, 2011
Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine. Tissue Eng Part B Rev (2012) 1.05
Gene delivery to bone. Adv Drug Deliv Rev (2012) 0.93
Orthopedic gene therapy--lost in translation? J Cell Physiol (2012) 0.93
Biological properties of solid free form designed ceramic scaffolds with BMP-2: in vitro and in vivo evaluation. PLoS One (2012) 0.92
Advances in regenerative orthopedics. Mayo Clin Proc (2013) 0.89
Perspectives on the interface of drug delivery and tissue engineering. Adv Drug Deliv Rev (2012) 0.85
Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater (2013) 0.83
Improvement of tendon repair using muscle grafts transduced with TGF-β1 cDNA. Eur Cell Mater (2012) 0.83
Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle. Eur Cell Mater (2015) 0.82
Non-viral gene-activated matrices: next generation constructs for bone repair. Organogenesis (2013) 0.79
Endochondral ossification for enhancing bone regeneration: converging native extracellular matrix biomaterials and developmental engineering in vivo. Tissue Eng Part B Rev (2014) 0.78
The potential impact of bone tissue engineering in the clinic. Regen Med (2016) 0.75
The Value of Systematic Reviews in Estimating the Cost and Barriers to Translation in Tissue Engineering. Tissue Eng Part B Rev (2016) 0.75
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci U S A (2010) 2.02
Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog (2009) 1.85
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
Gene therapy finds its niche. Nat Biotechnol (2011) 1.70
Medicine. A history lesson for stem cells. Science (2009) 1.64
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
iPS cell technology in regenerative medicine. Ann N Y Acad Sci (2010) 1.23
Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng (2007) 1.21
Tissue engineering: the hope, the hype, and the future. Tissue Eng (2006) 1.21
More than just bare scaffolds: towards multi-component and decorated fibrous biomaterials. Chem Soc Rev (2010) 1.11
Tissue engineering strategies for the regeneration of orthopedic interfaces. Ann Biomed Eng (2010) 1.10
Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev (2010) 1.10
Induction of pluripotency by defined factors. Exp Cell Res (2010) 1.09
Gene therapy for bone healing. Expert Rev Mol Med (2010) 1.02
History of tissue engineering and a glimpse into its future. Tissue Eng (2006) 0.89
Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry. Tissue Eng Part A (2010) 0.88
Translation of science to surgery: linking emerging concepts in biological cartilage repair to surgical intervention. J Bone Joint Surg Br (2010) 0.85
Embryonic stem cells for osteo-degenerative diseases. Methods Mol Biol (2011) 0.84
Commercial development of cell-based therapeutics: strategic considerations along the drug to tissue spectrum. Regen Med (2009) 0.83
Challenges in tissue engineering and regenerative medicine product commercialization: building an industry. Tissue Eng Part A (2010) 0.83
Building off-the-shelf tissue-engineered composites. Philos Trans A Math Phys Eng Sci (2010) 0.83
Skeletal stem cells and bone regeneration: translational strategies from bench to clinic. Proc Inst Mech Eng H (2010) 0.83